Suggestions
James Schroeder
EVP/Life Science Practice Group/Cell & Gene Therapy Specialist
James Schroeder is a Senior Vice President and a prominent figure in the Life Science Practice Group at JLL (Jones Lang LaSalle), where he specializes in Cell and Gene Therapy. He has been with JLL since November 2015, operating out of their MetroPark, NJ office. With over 20 years of experience in commercial real estate, Schroeder has developed a strong focus on the Life Sciences sector, particularly in the areas of gene therapy and biologics.13
Professional Background
Experience and Expertise::
- Prior to joining JLL, Schroeder spent a decade working at Novartis Pharmaceuticals, which provided him with valuable insights into the Life Sciences industry. This experience has greatly informed his approach to real estate transactions within this specialized field.1
- At JLL, he leads the Global Life Science Practice Group and has successfully managed numerous significant transactions for high-profile clients, including Catalent Pharma and Beam Therapeutics. His work often involves site selection, negotiation, and the construction of specialized facilities tailored for life sciences applications.24
Key Transactions:: Schroeder's portfolio includes managing over 25 million square feet of transactions across various sectors within Life Sciences. Some notable assignments include:
- Catalent Pharmaceuticals: 7 million square feet as portfolio manager.
- Beam Therapeutics: 100,000 square feet for gene therapy manufacturing.
- LabCorp: 400,000 square feet for diagnostics facilities.13
Current Role
In his current role at JLL, James Schroeder is recognized as a leader in the rapidly evolving Cell and Gene Therapy markets. His responsibilities encompass:
- Developing strategies for site selection and facility construction.
- Negotiating leases and managing real estate transactions that cater specifically to the needs of life sciences companies.2
Schroeder's extensive background in pharmaceuticals combined with his commercial real estate expertise positions him as a key player in facilitating growth within the Life Sciences sector.
